Intrinsic Value of S&P & Nasdaq Contact Us

iRhythm Technologies, Inc. IRTC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
58/100
4/7 Pass
SharesGrow Intrinsic Value
$1,387.90
+1026.3%
Analyst Price Target
$210.91
+71.2%

iRhythm Technologies, Inc. (IRTC) reported total assets of $1.02B and total liabilities of $867.3M for fiscal year 2025, resulting in total equity of $152.75M.

The company held $583.76M in cash and short-term investments. Total debt stood at $731.18M, with net debt of $495.17M. The Debt-to-Equity (D/E) ratio was 4.79 (leveraged).

Current ratio is 4.63, indicating strong short-term liquidity. Interest coverage is -2.8x (weak).

Criteria supported by this page:

  • HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (70/100) — Total assets $1.02B and equity $152.75M support the company's competitive scale
  • VALUE (100/100) — Debt-to-Equity 4.79 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 58/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
58/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
70/100
→ Income
GROWTH
100/100
→ Income
INCOME
10/100
→ Income
iRhythm Technologies, Inc. Balance Sheet History
Metric FY2025 FY2024 FY2023 FY2022
Total Assets $1.02B$931.45M$433.14M$448.22M
Total Liabilities $867.3M$840.54M$223.05M$208.41M
Total Debt $731.18M$736.91M$129.82M$131.04M
Cash & Investments $583.76M$535.55M$133.76M$213.14M
Total Stockholders Equity $152.75M$90.91M$210.1M$239.81M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message